GlobalData on MSN12h
Senseera secures $7.1m in funding to advance liquid biopsy platform
The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.
Senseera Raises $7.1 Million Seed Round Led by Lightspeed Venture Partners
Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a $7.1 million seed ...
Breast Cancer Liquid Biopsy Market to hit USD 1.9 billion by 2032, says Global Market Insights Inc.
Breast cancer liquid biopsy industry is projected to witness a CAGR of 22.6% during the period 2024-2032. This growth can be ...
gut.bmj5d
Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study
Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...
The American Journal of Managed Care7d
Revolutionizing Lung Cancer Care: The Impact of Liquid Biopsies
Edgardo S. Santos, MD, FACP, FASCO, highlighted how liquid biopsies are transforming lung cancer care by enabling faster, ...
Lung cancer deaths cut by 40% in biomarker test trial
Groundbreaking research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of lung ...
news.stv15h
Lung cancer trial reveals 40% drop in deaths using biomarker testing
Large-scale study found testing led to 40% reduction in deaths from lung cancer and other causes over five years.
Fife Free Press8h
St Andrews University professor’s groundbreaking research on lung cancer deaths
Groundbreaking research from the University of St Andrews’ School of Medicine has found that biomarker testing in individuals at risk of lung cancer led to a major reduction in deaths.